Borbone, Eleonora
Borbone, Eleonora
Istituto di Endocrinologia e Oncologia Sperimentale ''G. Salvatore'' - IEOS
The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin.
2013 D'Angelo D; Borbone E; Palmieri D; Uboldi S; Esposito F; Frapolli R; Pacelli R; D'Incalci M; Fusco A.
Tumour Suppressor Role of the CL2/DRO1/CCDC80 Gene in Thyroid Carcinogenesis.
2013 Ferraro A; Schepis F; Leone V; Federico A; Borbone E; Pallante P; Berlingieri MT; Chiappetta G; Monaco M; Palmieri D; Chiariotti L; Santoro M; Fusco A.
Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2.
2012 Esposito, F; Tornincasa, M; Pallante, P; Federico, A; Borbone, E; Pierantoni, Gm; Fusco, A
Oncogenic alterations in papillary thyroid cancers of young patients.
2012 Sassolas, G; Hafdinejjari, Z; Ferraro, A; Decaussinpetrucci, M; Rousset, B; Borsonchazot, F; Borbone, E; Berger, N; Fusco, A
Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas.
2011 Borbone, E; Troncone, G; Ferraro, A; Jasencakova, Z; Stojic, L; Esposito, F; Hornig, N; Fusco, A; Orlando, V
Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation.
2010 Borbone, E; Berlingieri, Mt; De Bellis, F; Nebbioso, A; Chiappetta, G; Mai, A; Altucci, L; Fusco, A
MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle
2007 Rosa Visone; Lucia Russo; Pierlorenzo Pallante;Ivana De Martino;Angelo Ferraro; Vincenza Leone; Eleonora Borbone; Fabio Petrocca;Hansjuerg Alder; Carlo Maria Croce;Alfredo Fusco.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin. | 1-gen-2013 | D'Angelo D; Borbone E; Palmieri D; Uboldi S; Esposito F; Frapolli R; Pacelli R; D'Incalci M; Fusco A. | |
| Tumour Suppressor Role of the CL2/DRO1/CCDC80 Gene in Thyroid Carcinogenesis. | 1-gen-2013 | Ferraro A; Schepis F; Leone V; Federico A; Borbone E; Pallante P; Berlingieri MT; Chiappetta G; Monaco M; Palmieri D; Chiariotti L; Santoro M; Fusco A. | |
| Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. | 1-gen-2012 | Esposito, F; Tornincasa, M; Pallante, P; Federico, A; Borbone, E; Pierantoni, Gm; Fusco, A | |
| Oncogenic alterations in papillary thyroid cancers of young patients. | 1-gen-2012 | Sassolas, G; Hafdinejjari, Z; Ferraro, A; Decaussinpetrucci, M; Rousset, B; Borsonchazot, F; Borbone, E; Berger, N; Fusco, A | |
| Enhancer of zeste homolog 2 overexpression has a role in the development of anaplastic thyroid carcinomas. | 1-gen-2011 | Borbone, E; Troncone, G; Ferraro, A; Jasencakova, Z; Stojic, L; Esposito, F; Hornig, N; Fusco, A; Orlando, V | |
| Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation. | 1-gen-2010 | Borbone, E; Berlingieri, Mt; De Bellis, F; Nebbioso, A; Chiappetta, G; Mai, A; Altucci, L; Fusco, A | |
| MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle | 1-gen-2007 | Rosa Visone; Lucia Russo; Pierlorenzo Pallante;Ivana De Martino;Angelo Ferraro; Vincenza Leone; Eleonora Borbone; Fabio Petrocca;Hansjuerg Alder; Carlo Maria Croce;Alfredo Fusco. |